UNITE4TB

Worldwide, Tuberculosis (TB) is one of the top 10 causes of death and a leading cause of death and suffering from a single infectious agent.

With 30 partners from 13 countries, UNITE4TB aims to set a new standard for anti-TB regimen development. The Consortium is working to upgrade the current clinical trial methodology and enhance the efficiency with which new regimens are delivered.